These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6953457)

  • 1. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test and primary obsessional compulsive disorder.
    Vallejo J; Olivares J; Marcos T; Martínez-Osaba MJ; Ribera F; Bulbena A
    Compr Psychiatry; 1988; 29(5):498-502. PubMed ID: 3180759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression tests in patients with obsessive-compulsive disorder.
    Lieberman JA; Kane JM; Sarantakos S; Cole K; Howard A; Borenstein M; Novacenko H; Puig-Antich J
    Am J Psychiatry; 1985 Jun; 142(6):747-51. PubMed ID: 4003598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls.
    Catapano F; Monteleone P; Maj M; Kemali D
    Neuropsychobiology; 1990; 23(2):53-6. PubMed ID: 2077433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal dexamethasone suppression test in obsessive-compulsive disorder.
    Monteiro W; Marks IM; Noshirvani H; Checkley S
    Br J Psychiatry; 1986 Mar; 148():326-9. PubMed ID: 3719227
    [No Abstract]   [Full Text] [Related]  

  • 8. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.
    Dratcu L; Calil HM
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(2):185-94. PubMed ID: 3585807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in schizo-affective depression.
    Katona CL; Roth M
    J Affect Disord; 1985; 8(2):107-12. PubMed ID: 3157718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in the interpretation of dexamethasone suppression test results in children: a review and report.
    Steingard R; Biederman J; Keenan K; Moore C
    Biol Psychiatry; 1990 Aug; 28(3):193-202. PubMed ID: 2198952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder.
    Kuloğlu M; Atmaca M; Onal S; Geçici O; Bulut V; Tezcan E
    Psychiatry Res; 2007 Jun; 151(3):265-70. PubMed ID: 17467061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test and REM sleep in patients with major depressive disorder.
    Mendlewicz J; Kerkhofs M; Hoffmann G; Linkowski P
    Br J Psychiatry; 1984 Oct; 145():383-8. PubMed ID: 6487911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test: a review of contemporary confusion.
    Carroll BJ
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):13-24. PubMed ID: 3881417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.